Richard G Vincent - Net Worth and Insider Trading
Richard G Vincent Net Worth
The estimated net worth of Richard G Vincent is at least $9,875 dollars as of 2024-11-13. Richard G Vincent is the CFO of Oncternal Therapeutics Inc and owns about 8,161 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $9,875. Details can be seen in Richard G Vincent's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard G Vincent has not made any transactions after 2023-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard G Vincent
Richard G Vincent Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard G Vincent owns 2 companies in total, including Oncternal Therapeutics Inc (ONCT) , and Sorrento Therapeutics Inc (SRNE) .
Click here to see the complete history of Richard G Vincent’s form 4 insider trades.
Insider Ownership Summary of Richard G Vincent
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-13 | Chief Financial Officer |
| SRNE | Sorrento Therapeutics Inc | 2010-02-05 | Chief Financial Officer |
Richard G Vincent Latest Holdings Summary
Richard G Vincent currently owns a total of 1 stock. Richard G Vincent owns 8,161 shares of Oncternal Therapeutics Inc (ONCT) as of April 13, 2023, with a value of $9,875.
Latest Holdings of Richard G Vincent
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-13 | 8,161 | 1.21 | 9,875 |
Holding Weightings of Richard G Vincent
Richard G Vincent Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard G Vincent has made a total of 3 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 1,500 shares on April 13, 2023, which cost Richard G Vincent around $9,000.
Insider Trading History of Richard G Vincent
- 1
Richard G Vincent Trading Performance
GuruFocus tracks the stock performance after each of Richard G Vincent's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard G Vincent is 2.18%. GuruFocus also compares Richard G Vincent's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard G Vincent within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard G Vincent's insider trading performs compared to the benchmark.
Performance of Richard G Vincent
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.1 | | | | | |
| Relative Return to S&P 500(%) | -6.39 | | | | | |
Richard G Vincent Ownership Network
Ownership Network List of Richard G Vincent
Ownership Network Relation of Richard G Vincent
Richard G Vincent Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Richard G Vincent is the Chief Financial Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Richard G Vincent made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 28,000 shares made by Gunnar F. Kaufmann , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 12,380 shares were bought by its insiders, resulting in a net purchase of 11,400 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Richard G Vincent Mailing Address
Above is the net worth, insider trading, and ownership report for Richard G Vincent. You might contact Richard G Vincent via mailing address: C/o Women First Health Care, 5355 Mira Sorrento Place Ste. 700, San Diego Ca 92121-3825.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
